CD30+ lymphomatoid skin toxicity secondary to ipilimumab
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2020-04-01
|
| Series: | JAAD Case Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S235251261630073X |
| _version_ | 1831518826738483200 |
|---|---|
| author | Amelia E. Bush, BS Andres Garcia, BS Janet Li, MD Jonathan Curry, MD Susan Y. Chon, MD |
| author_facet | Amelia E. Bush, BS Andres Garcia, BS Janet Li, MD Jonathan Curry, MD Susan Y. Chon, MD |
| author_sort | Amelia E. Bush, BS |
| collection | DOAJ |
| first_indexed | 2024-12-13T12:43:42Z |
| format | Article |
| id | doaj.art-0414a2fda83b447693ead3ee0d9b2eab |
| institution | Directory Open Access Journal |
| issn | 2352-5126 |
| language | English |
| last_indexed | 2024-12-13T12:43:42Z |
| publishDate | 2020-04-01 |
| publisher | Elsevier |
| record_format | Article |
| series | JAAD Case Reports |
| spelling | doaj.art-0414a2fda83b447693ead3ee0d9b2eab2022-12-21T23:45:33ZengElsevierJAAD Case Reports2352-51262020-04-0164251253CD30+ lymphomatoid skin toxicity secondary to ipilimumabAmelia E. Bush, BS0Andres Garcia, BS1Janet Li, MD2Jonathan Curry, MD3Susan Y. Chon, MD4University of Texas Medical School at Houston, Houston, TexasUniversity of Texas Medical School at Houston, Houston, TexasDepartment of Dermatology, University of Texas at Houston, Houston, TexasDepartment of Pathology and Dermatology, MD Anderson of Houston, Houston, TexasDepartment of Pathology and Dermatology, MD Anderson of Houston, Houston, Texas; Department of Dermatology, Houston, Texas; Correspondence to: Susan Y. Chon, MD, 1400 Pressler St Unit 1452, Houston, TX 77030.http://www.sciencedirect.com/science/article/pii/S235251261630073XCD30drug eruptionimmune checkpoint therapyipilimumablymphoproliferative reactionpseudolymphoma |
| spellingShingle | Amelia E. Bush, BS Andres Garcia, BS Janet Li, MD Jonathan Curry, MD Susan Y. Chon, MD CD30+ lymphomatoid skin toxicity secondary to ipilimumab JAAD Case Reports CD30 drug eruption immune checkpoint therapy ipilimumab lymphoproliferative reaction pseudolymphoma |
| title | CD30+ lymphomatoid skin toxicity secondary to ipilimumab |
| title_full | CD30+ lymphomatoid skin toxicity secondary to ipilimumab |
| title_fullStr | CD30+ lymphomatoid skin toxicity secondary to ipilimumab |
| title_full_unstemmed | CD30+ lymphomatoid skin toxicity secondary to ipilimumab |
| title_short | CD30+ lymphomatoid skin toxicity secondary to ipilimumab |
| title_sort | cd30 lymphomatoid skin toxicity secondary to ipilimumab |
| topic | CD30 drug eruption immune checkpoint therapy ipilimumab lymphoproliferative reaction pseudolymphoma |
| url | http://www.sciencedirect.com/science/article/pii/S235251261630073X |
| work_keys_str_mv | AT ameliaebushbs cd30lymphomatoidskintoxicitysecondarytoipilimumab AT andresgarciabs cd30lymphomatoidskintoxicitysecondarytoipilimumab AT janetlimd cd30lymphomatoidskintoxicitysecondarytoipilimumab AT jonathancurrymd cd30lymphomatoidskintoxicitysecondarytoipilimumab AT susanychonmd cd30lymphomatoidskintoxicitysecondarytoipilimumab |